The groundbreaking approach of this peptide represents a exciting development in the management of type 2 diabetes. Distinct from existing therapies, tirzepatide impacts dual pathways – GLP-1 and GIP – leading to https://tirzepatide-peptide016902.activosblog.com/40543930/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment